Ibodutant. Tachykinin NK2 receptor antagonist treatment of irritable bowel syndrome

Drugs of the Future

Volumn 33, Issue 2, 2008, Pages 111-115

  Giuliani, Sandro ^a   Altamura, Maria ^a   Maggi, Carlo Alberto ^a  

^a Menarini Ricerche SpA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IBODUTANT; MEN 15596; TACHYKININ RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL TRIAL; COLORECTAL DISEASE; DOSE RESPONSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG HALF LIFE; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG SAFETY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HYPERALGESIA; IRRITABLE COLON; NONHUMAN; REPEATED DRUG DOSE; SINGLE DRUG DOSE;

EID: 41549104892     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.2008.033.02.1181381     Document Type: Article

References (13)

1. Fedi, V., Altamura, M., Catalioto, R.M. et al. Discovery of a series of potent and selective linear tachykinin NK2 receptor antagonists. J Med Chem 2007, 50(20): 4793-807.
2. Maggi, C.A., Patacchini, R., Santicioli, P. et al. Human isolated ileum: Motor responses of the circular muscle to electrical field stimulation and exogenous neuropeptides. Naunyn Schmiedeberg's Arch Pharmacol 1990, 341(3): 256-61.
3. Giuliani, S., Barbanti, G., Turini, D., Quartara, L., Rovero, P., Giachetti, A., Maggi, C.A. NK2 tachykinin receptors and contraction of circular muscle of the human colon: Characterization of the NK2 receptor subtype. Eur J Pharmacol 1991, 203(3): 365-70.
4. Schuiling, M., Zuidhof, A.B., Meurs, H., Zaagsma, J. Role of tachykinin NK2 receptor activation in allergen-induced late asthmatic reaction, airway hyperreactivity and airway inflammatory cells influx in conscious, unrestrained guinea-pigs. Br J Pharmacol 1999, 127(4): 1030-8.
5. Toulouse, M., Coelho, A.M., Fioramonti, J., Lecci, A., Maggi, C.A., Buéno, L. Role of tachykinin NK2 receptors in normal and altered rectal sensitivity in rats. Br J Pharmacol 2000, 129(1): 193-9.
6. Lordal, M., Navalesi, G., Theodorsson, E., Maggi, C.A., Hellstrom, P.M. A novel tachykinin NK2 receptor antagonist prevents motility-stimulating effects of neurokinin A in small intestine. Br J Pharmacol 2001, 134(1): 215-23.
7. Lecci, A., Capriati, A., Maggi, C.A. Tachykinin NK2 receptor antagonists for the treatment of irritable bowel syndrome. Br J Pharmacol 2004, 141(8): 1249-63.
8. Drossman, D.A., Camilleri, M., Mayer, E., Whitehead, W.E. AGA technical review on irritable bowel syndrome. Gastroenterology 2002, 123(6): 2108-31.
9. Spanier, J.A., Howden, C.W., Jones, M.P. A systematic review of alternative therapies in the irritable bowel syndrome. Arch Intern Med 2003, 163(3): 265-74.
10. Fedi, V., Altamura, M., Balacco, G. et al. Insertion of an aspartic acid moiety into cyclic pseudopeptides: Synthesis and biological characterization of potent antagonists for the human tachykinin NK-2 receptor. J Med Chem 2004, 47(27): 6935-47.
11. Sisto, A., Altamura, M., Cardinali, F., D'Andrea, P., Rossi, C., Fattori, D. α,α-Cyclic aminoacids as useful scaffolds for the preparation of hNK2 receptor antagonists. Bioorg Med Chem Lett 2007, 17(17): 4841-4.
12. Cialdai, C., Tramontana, M., Patacchini, R. et al. MEN15596, a novel nonpeptide tachykinin NK2 receptor antagonist. Eur J Pharmacol 2006, 549(1-3): 140-8.
13. Lecci, A., Maggi C.A. Peripheral tachykinin receptors as potential therapeutic targets in visceral diseases. Expert Opin Ther Targets 2003, 7(3): 343-62.